Morgan Stanley Morphic Holding, Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024
SELL
$26.12 - $34.07 $1.78 Million - $2.32 Million
-68,209 Reduced 30.92%
152,366 $5.19 Million
Q2 2024

Aug 14, 2024
SELL
$26.12 - $34.07 $1.78 Million - $2.32 Million
-68,209 Reduced 30.92%
152,366 $5.19 Million
Q1 2024

Oct 17, 2024
BUY
$26.64 - $40.31 $1.82 Million - $2.75 Million
68,209 Added 44.77%
220,575 $7.76 Million
Q1 2024

Aug 16, 2024
SELL
$26.64 - $40.31 $12.7 Million - $19.2 Million
-475,345 Reduced 68.3%
220,575 $7.76 Million
Q1 2024

May 15, 2024
SELL
$26.64 - $40.31 $12.7 Million - $19.2 Million
-475,345 Reduced 68.3%
220,575 $7.76 Million
Q4 2023

Aug 16, 2024
BUY
$19.95 - $31.0 $10.8 Million - $16.9 Million
543,554 Added 356.74%
695,920 $20.1 Million
Q4 2023

Feb 13, 2024
BUY
$19.95 - $31.0 $3.34 Million - $5.19 Million
167,482 Added 31.69%
695,920 $20.1 Million
Q3 2023

Nov 15, 2023
BUY
$21.33 - $59.42 $5.67 Million - $15.8 Million
265,627 Added 101.07%
528,438 $12.1 Million
Q2 2023

Aug 14, 2023
BUY
$34.33 - $62.11 $3.96 Million - $7.17 Million
115,453 Added 78.35%
262,811 $15.1 Million
Q1 2023

May 15, 2023
SELL
$26.01 - $48.69 $1.56 Million - $2.92 Million
-60,038 Reduced 28.95%
147,358 $5.55 Million
Q4 2022

Feb 14, 2023
SELL
$24.14 - $30.37 $1.03 Million - $1.3 Million
-42,821 Reduced 17.11%
207,396 $5.55 Million
Q3 2022

Nov 14, 2022
SELL
$22.23 - $33.37 $3.59 Million - $5.38 Million
-161,300 Reduced 39.2%
250,217 $7.08 Million
Q2 2022

Oct 27, 2022
BUY
$19.74 - $43.01 $3.78 Million - $8.24 Million
191,656 Added 87.17%
411,517 $8.93 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $43.01 $3.78 Million - $8.24 Million
191,656 Added 87.17%
411,517 $8.93 Million
Q1 2022

Oct 27, 2022
SELL
$36.25 - $52.02 $6.95 Million - $9.97 Million
-191,656 Reduced 46.57%
219,861 $8.83 Million
Q1 2022

May 13, 2022
BUY
$36.25 - $52.02 $3.86 Million - $5.54 Million
106,424 Added 93.82%
219,861 $8.83 Million
Q4 2021

Feb 14, 2022
BUY
$43.27 - $65.72 $2.58 Million - $3.92 Million
59,614 Added 110.76%
113,437 $5.38 Million
Q3 2021

Nov 15, 2021
BUY
$53.61 - $67.5 $2.89 Million - $3.63 Million
53,823 New
53,823 $3.05 Million

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email